Optimized Psycho-oncological Care Through an Interdisciplinary Care Algorithm
NCT ID: NCT04638699
Last Updated: 2023-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
900 participants
INTERVENTIONAL
2020-04-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis
NCT01859429
Somatic-psychosocial Care Concept for Oncologic Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
NCT00804817
Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.
NCT07168096
Longitudinal Analysis of Mental Disorders, Psychosocial Distress and Care Needs of Patients and Their Relatives
NCT04620564
Impact of Onco-sexology Support on the Quality of Life of Patients Newly Diagnosed for Cancer
NCT06332573
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Within the framework of this multicenter study (Hannover, Leipzig and Dresden), a newly designed training of nursing staff ("OptiScreen training") on mental stress and psycho-oncological care is intended to increase the precise identification of mentally stressed patients in need of treatment, to increase the allocation of these patients to psycho-oncology and to improve interdisciplinary cooperation.
Aims of the study:
1. targeted, needs-based allocation to psycho-oncology
2. increasing the acceptance of psycho-oncological screening by patients\* and treatment team
3. increase of patient competence and satisfaction
4. increasing the acceptance of psycho-oncological treatment by patients and treatment team In summary, the findings of this multi-center study should contribute to the improvement of interdisciplinary cooperation, improve the demand-oriented and targeted allocation of psychologically burdened patients to psycho-oncological care and thus develop a "best practice model" of an interdisciplinary care algorithm.
Methodology
The study will include inpatients from the visceral oncology centers at the three sites who have the necessary cognitive, physical and linguistic abilities. The study is divided into 2 phases:
Phase 1: Survey of the current status For this purpose, N = 300 patients\* in the visceral oncology centers are interviewed with a questionnaire during the inpatient stay (t0) and three months later (t1).
The data collected will include psychological stress, disease management/treatment, quality of life and treatment satisfaction of persons with oncological diseases. In addition, the needs for information and support, the practicability as well as the allocation to psycho-oncological care and its utilization will be surveyed.
Execution of the "OptiScreen training": special psycho-oncological training of the nursing staff for basic knowledge about the experience of psychological stress as well as diagnostics of psychosocial stress will take place after the completion of phase 1.
Phase 2: survey after the OptiScreen training Analogous to phase 1, N = 600 patients\* in the visceral oncology centers are interviewed during the inpatient stay (t0) and three months later (t1).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 1 Survey of the actual state
No interventions assigned to this group
Phase 2 Survey after the OptiScreen training
OptiScreen training
Special psycho-oncological training for nursing staff to acquire basic knowledge about the experience of mental stress as well as diagnostics of psychosocial stress
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OptiScreen training
Special psycho-oncological training for nursing staff to acquire basic knowledge about the experience of mental stress as well as diagnostics of psychosocial stress
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Leipzig
OTHER
UniversitätsKrebsCentrum Dresden
UNKNOWN
Hannover Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zimmermann, Tanja Prof. Dr.
Prof. Dr. Tanja Zimmermann
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tanja Zimmermann
Role: PRINCIPAL_INVESTIGATOR
Hannover Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hannover Medical School
Hanover, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tanja Zimmermann
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
70113550
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.